Glutaraldehyde gelification time-a highly acceptable bedside tool in the assessment of children tuberculosis

Simple item page
dc.contributor.authorNe Winen_US
dc.contributor.authorKhin Sween_US
dc.contributor.authorThein Thein Myinten_US
dc.contributor.authorSaw Mya Yeeen_US
dc.date.accessioned2009-06-30T09:01:12Z
dc.date.available2009-06-30T09:01:12Z
dc.date.created1998-04-01en_US
dc.date.issued1998-04-01en_US
dc.description.abstractGlutarldehyde gelification time (GGT) was determined three times in fifty-three children with the clinical diagnosis of tuberculosis supported by CxR evidence, once before the initiation of treatment (GGTO) and twice within six months of antituberculous treatment, at three months interval (GGT3 and GGT6 respectively). The values of GGTO are shortened in 46 cases (86.8 per cent). GGT3 and GGT6 revealed shorten in 27 cases (50.9 per cent) and 6 cases (11.3 per cent ) respectively. This significant change of GGT during treatment could be used as a supportive evidence to clinical judgment in the assessment of response to treatment in childhood tuberculosis.en_US
dc.identifier.citationNe Win, Khin Swe, Thein Thein Myint, Saw Mya Yee. Glutaraldehyde gelification time-a highly acceptable bedside tool in the assessment of children tuberculosis. Myanmar Health Sciences Research Journal. 1998; 10(1): 48-50en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/127070
dc.subject.meshTuberculosisen_US
dc.subject.meshGlutaralen_US
dc.subject.meshMyanmaren_US
dc.titleGlutaraldehyde gelification time-a highly acceptable bedside tool in the assessment of children tuberculosisen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Myanmar Health Sciences Research Journal